• 1. Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, P. R. China;
  • 2. Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100005, P. R. China;
JIAO Peng, Email: jp_bird@126.com
Export PDF Favorites Scan Get Citation

Elderly patients with lung cancer have a significantly increased risk of perioperative cardiopulmonary complications due to physiological decline, high incidence of complications and reduced surgical tolerance, which directly affects postoperative recovery and long-term survival. Although the concepts of minimally invasive surgery and enhanced recovery after surgery have improved clinical outcomes, early recognition and intervention of postoperative complications in elderly patients remains a significant challenge in the field of thoracic surgery. By integrating recent literature and clinical practice, this paper systematically analyzes the pathophysiological mechanism and risk factors of perioperative cardiopulmonary complications in elderly patients with lung cancer, and discusses individualized intervention strategies based on risk stratification and multidisciplinary team, in order to provide theoretical basis and practical guidance for optimizing perioperative management and improving postoperative prognosis in elderly patients.

Citation: SONG Yuhao, TIAN Wenxin, LI Donghang, WU Jiangyu, YU Hanbo, TONG Hongfeng, SUN Yaoguang, JIAO Peng. Early recognition and intervention strategy of perioperative cardiopulmonary complications in elderly patients with lung cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2026, 33(5): 710-716. doi: 10.7507/1007-4848.202508058 Copy

Copyright ? the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress of post-translational modifications of programmed death-1 in tumor immunotherapy
  • Next Article

    Research advances in the role of cell cycle dysregulation in the development and progression of pancreatic ductal adenocarcinoma